This indicates that drugs, which are substrates of ABCC1, can accumulate easily in skin cells when the patients develop skin cancer such as malignant melanoma, potentially increasing the risk of developing drug-induced skin diseases. The gene discussed is ABCC1; the disease is melanoma.